Wyndham Hotels & Resorts (WH) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
19 Feb, 2026Executive summary
Achieved 4% net room growth in 2025, with record 870 deals signed and a global pipeline of nearly 260,000 rooms and over 2,200 hotels.
Largest global hotel franchisor with 8,300+ hotels and 869,000 rooms across 100 countries, focusing on select-service, asset-light, leisure-driven business model.
Technology and AI investments enhanced guest experience, owner returns, and operational efficiency, including AI-powered booking and guest engagement platforms.
Returned $393 million to shareholders in 2025 through $266 million in share repurchases and $127 million in dividends.
Faced a challenging RevPAR environment, with global RevPAR down 6% in Q4 and U.S. RevPAR down 4% for the year, but saw improvement in early 2026.
Financial highlights
Adjusted EBITDA for 2025 reached $718 million, up 4% year-over-year on a comparable basis.
Adjusted diluted EPS for 2025 rose 6% to $4.58; adjusted net income increased 2% to $353 million.
Net income for 2025 was $193 million, down 33% due to non-cash impairment and other charges.
Ancillary revenues grew 15% year-over-year to $317 million, driven by co-branded card and license fees.
Adjusted free cash flow was $433 million, with a 60% conversion rate from Adjusted EBITDA and a 7.5% yield.
Outlook and guidance
2026 system-wide room growth targeted at 4.0%-4.5%; Q1 flat sequentially due to 3,000 room terminations, growth resuming in Q2.
Global RevPAR projected between +0.5% and -1.5%; U.S. RevPAR Q1 expected -3% to -2%, with Q2-Q4 expected to be flat.
Adjusted EBITDA projected at $730-$745 million (2%-4% growth); adjusted diluted EPS at $4.62-$4.80.
Free cash flow conversion before development advances expected at 55%-60%.
Board authorized a 5% increase in quarterly dividend to $0.43 per share for 2026.
Latest events from Wyndham Hotels & Resorts
- Strong 2025 results, robust governance, and ESG focus; board opposes written consent proposal.WH
Proxy filing25 Mar 2026 - Annual meeting to vote on directors, pay, auditor, and written consent proposal.WH
Proxy filing25 Mar 2026 - Q2 saw 4% room growth, 22% higher adjusted EPS, and record pipeline expansion.WH
Q2 20242 Feb 2026 - Q3 delivered 4% room growth, $208M EBITDA, record pipeline, and raised 2024 guidance.WH
Q3 202418 Jan 2026 - Record system growth, strong earnings, and new initiatives drive a positive 2025 outlook.WH
Q4 202429 Dec 2025 - Record growth, strong financials, and robust governance drive positive outlook for 2025.WH
Proxy Filing1 Dec 2025 - Director elections, executive pay, and auditor ratification headline the annual meeting agenda.WH
Proxy Filing1 Dec 2025 - Record room and pipeline growth, but 2025 guidance lowered on RevPAR softness.WH
Q1 20251 Dec 2025 - System and pipeline growth offset RevPAR declines, driving higher earnings and strong cash returns.WH
Q3 202524 Oct 2025